Trials / Completed
CompletedNCT04406402
L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols
The Effects of Different Acute Nutritional Protocols and Lifestyle Modification on Circulating L-arginine and Asymmetric Dimethylarginine (ADMA) in Obese and Type 2 Diabetic Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 243 (actual)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Low serum L-arginine (Arg) and high asymmetric dimethylarginine (ADMA) can predict microvascular complications in type 2 diabetes (T2DM). The investigators examined whether or not Arg and ADMA are affected by dietary factors or lifestyle modification in overweight/ obese and T2DM subjects.
Detailed description
The investigators tested the effects on serum Arg and ADMA of a) a single load of ingested dextrose, protein, fat or alcohol, each consumed within 10 minutes; b) a single episode of physical exercise; c) a 12 weeks lifestyle modification program comprised of a standard dietary and physical activity counseling in obese or T2DM subjects on circulating Arg and ADMA (n=43)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Acute dietary protocols and lifestyle modification | The investigators tested the effects on serum Arg and ADMA of a) a single load of ingested dextrose, protein, fat or alcohol, each consumed within 10 minutes; b) a single episode of physical exercise; c) a 12 weeks lifestyle modification program comprised of a standard dietary and physical activity counseling in obese or T2DM subjects on circulating Arg and ADMA (n=43). |
Timeline
- Start date
- 2006-12-05
- Primary completion
- 2008-04-04
- Completion
- 2008-12-10
- First posted
- 2020-05-28
- Last updated
- 2020-06-02
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04406402. Inclusion in this directory is not an endorsement.